Artificial Intelligence
Todos Medical Provides Corporate Update
- 3CL Pharma prepares to crowdfund for Long COVID trials of Tollovir™ and Tollovid™
- CEO to Present at Emerging Growth Conference on Wednesday, October 12, 2022 at 2pm ET
New York, NY, and Tel Aviv, ISRAEL, Oct. 11, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today provided a corporate update for shareholders. The company will give a presentation at the Emerging Growth Conference on Wednesday, October 12, 2022 at 2:00pm EST.
Event: Emerging Growth Conference
Presentation Date: Wednesday October 12, 2022
Time: 2:00pm Eastern Time (ET)
Register to Attend: https://goto.webcasts.com/starthere.jsp?ei=1571724&tp_key=4274f13b29&sti=tomdf
Commercial PCR Testing Business
The Company’s CLIA/CAP-certified clinical testing lab Provista Diagnostics recently completed a successful launch of its suite of PCR testing services for Urinary Tract Infection (UTI), Wound, Respiratory Pathogen (RP), Gastrointestinal (GI) and Sexually Transmitted Infections (STI), COVID and MonkeyPox in Dunnellon, Florida where it onboarded multiple providers including urgent care centers, specialty care practices such as podiatry, skilled nursing facilities and hospitals. The focus of Provista’s commercial operations has transitioned beyond high volume COVID testing towards integrated genetic testing solutions with fast turnaround time and more insightful treatment recommendations. This empowers providers with a PCR biomarker data toolkit that improves patient outcomes and reduces the overall cost of care. Our soft launch was successful and we learned a number of lessons which enable us to prepare marketing collateral for the full-scale launch in the broader rural area around Dunnellon which is also underserved by the major lab testing companies. Once this full-scale launch is complete, we intend to duplicate this effort in other strategic rural underserved areas around the United States where we expect our program can provide similar results. The Company expects the new PCR testing business to become material to the Company’s financials in the fourth quarter of 2022 and will initiate protocols to add cancer genetics and pharmacogenomic testing to further improve its genomics offering.
The Company intends to remain on the leading edge of pandemic preparedness with its high-capacity PCR COVID and MonkeyPox offerings. We are now preparing to submit an Emergency Use Authorization application to the US FDA for a saliva-based MonkeyPox diagnostic test, as well as continue to build towards wastewater testing capabilities for COVID, MonkeyPox, Polio, and other pandemic pathogens which we expect to become more common in public wastewater settings, as well as septic tank settings for homes and edifices not connected to sewer systems.
Long COVID is a poorly quantified heterogenous disease that requires in depth testing and analysis to help manage the significant symptoms and underlying viral persistence driving the disease pathophysiology. Our Long COVID Panel partnership with Amerimmune Diagnostics was established to monitor immune system markers relevant to T cell exhaustion, B cell activation, and neutralizing antibody production. Profiling Long COVID via biomarkers empowers clinicians to more closely monitor the outcomes from treatment and supplement recommendations. As our understanding of Long COVID improves we plan to add key markers related to cardiovascular (CV) risk assessment and viral persistence. Sample collection is available through Quest Diagnostics collection network in all states with the exception of New York and California, and can be ordered through a patient’s primary care physician. As we begin to raise awareness for this key tool for Long Haulers, we expect they will become more aware of our antiviral supplement Tollovid.
Development-stage Proprietary Testing
The Company intends to commercialize the Videssa breast cancer blood test in 2023. We have collected the first 40 blood samples from an up to 750 patient study from participants being enrolled in a clinical trial in Mexico. These samples should allow us to complete the analytical and clinical validation for Videssa as a laboratory-development test (LDT) and launch at Provista. The blood work will also allow for ex-US regulatory authorization and set the stage for a pivotal study for Videssa to achieve clinical utility data in the United States for Videssa in breast cancer.
Upon the launch of Videssa, the Company will be positioned to generate patient-matched data for its Total Biochemical Infrared Analysis (TBIA) artificial intelligence (AI) cancer blood testing platform. This will allow TBIA to generate matched relevant patient datasets to perfect its algorithms and produce sufficient data to allow for submission to the US FDA. While in development alongside Videssa, we believe that TBIA will be able to rapidly accelerate its path to market for all cancers, including breast cancer. Additionally, the Company’s Alzheimer’s blood testing platform LymPro expects to read out on key data related to correlation with amyloid PET scan in the fourth quarter of 2022.
Todos Botanicals
The Company recently formed Todos Botanicals to serve as the long term solution for manufacturing of our 3CL Pharma subsidiary’s Tollovid product(s). With these manufacturing capabilities now in-hand, we are also able to manufacture other botanical products, including CBD and other 0% THC products, that could ultimately prove complementary to Tollovid in terms of immune support dietary supplements. We recently entered into an agreement with Nerd Hemp to supply Tollovid and white-labeled CBD products under a $50M supply agreement. The products are being deployed through Nerd Hemp’s automated retail machines, initially contracted to be deployed into 5,500 locations throughout the United States. The Company is now finalizing its first purchase order under the agreement and is also steadily building up its CBD white-label customer base.
3CL Pharma majority-owned subsidiary
The Company is now in the final stages of preparing the crowdfunding campaign for its majority owned subsidiary 3CL Pharma that is developing the dual-mechanism 3CL protease inhibitor and CCR5 antagonist drug candidate Tollovir™, the 3CL protease inhibitor dietary supplement Tollovid™ and our protease persistence diagnostic test TolloTest™.
Tollovir has generated data from a Phase 2 trial in hospitalized patients that showed benefits in mortality, time in the hospital, oxygen saturation levels and immune biomarkers. The Company is preparing for an extension of its current Phase 2 study to gather sufficient data to engage with regulators related to an Emergency Use Authorization for hospitalized COVID patients to reduce death. Concurrently, we have received significant interest from institutional investors and not-for-profit organizations in trials for Tollovir in Long COVID and we have a trial plan in place to initiate Phase 2 development largely as a result of the positive feedback patients have provided on the supplement version, Tollovid, which is being used by Long COVID patients. A Phase 2 trial is also planned for Tollovid. We have also seen an increased interest in the use of Tollovid as an herbal remedy for settings where Pfizer’s drug Paxlovid is not authorized to be used, including in younger vaccinated individuals, after Paxlovid 5-day treatment period has ended and in pediatric cases under pediatrician supervision.
We are continuing to pursue strategic options for the further development of the TolloTest as a point-of-care viral persistence test and intend to first bring the technology to the United States for validation at Provista and for inclusion in our Long COVID Panel partnership with Amerimmune.
New York Stock Exchange listing
The Company is now pursuing a national stock exchange listing with the New York Stock Exchange through the NYSE American Exchange. We expect to provide further details in the weeks ahead.
About Todos Medical Ltd.
Founded in Rehovot, Israel with offices in New York City, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic solutions for the early detection of a variety of cancers. The Company’s state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that examines cancer’s influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma. Todos’ two internally developed cancer-screening tests, TMB-1 and TMB-2 have received a CE mark in Europe. Todos recently acquired U.S.-based medical diagnostics company Provista Diagnostics, Inc. to gain rights to its Alpharetta, Georgia-based CLIA/CAP certified lab currently performing PCR COVID testing, Long COVID Panel analyses, and Provista’s proprietary commercial-stage Videssa® breast cancer blood test. More information on Provista is available at www.provistadx.com.
Todos is also developing blood tests for the early detection of neurodegenerative disorders, such as Alzheimer’s disease. The Lymphocyte Proliferation Test (LymPro Test™) is a diagnostic blood test that determines the ability of peripheral blood lymphocytes (PBLs) and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle. It is believed that certain diseases, most notably Alzheimer’s disease, are the result of compromised cellular machinery that leads to aberrant cell cycle re-entry by neurons, which then leads to apoptosis. LymPro is unique in the use of peripheral blood lymphocytes as a surrogate for neuronal cell function, suggesting a common relationship between PBLs and neurons in the brain.
Todos formed the Israeli-based majority-owned joint venture 3CL Pharma, Ltd with NLC Pharma in March of 2022 to consolidate all of the intellectual property surrounding 3CL protease–based diagnostic testing and development of 3CL protease botanical and pharmaceutical inhibitors that target a fundamental reproductive mechanism of coronaviruses. 3CL Pharma, through Todos’ brand, has commercialized the 3CL protease inhibitor immune support dietary supplement Tollovid™ in the United States, is developing the dual mechanism 3CL protease inhibitor and anti-cytokine therapeutic drug candidate Tollovir™, while also developing the 3CL protease diagnostic TolloTest™.
To purchase Tollovid please visit Amazon or www.MyTollovid.com. For more information, please visit https://www.todosmedical.com/.
Forward-looking Statements
Certain statements contained in this press release may constitute forward-looking statements. For example, forward-looking statements are used when discussing our expected clinical development programs and clinical trials. These forward-looking statements are based only on current expectations of management, and are subject to significant risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval or patent protection for product candidates; competition from other biotechnology companies; and our ability to obtain additional funding required to conduct our research, development and commercialization activities. In addition, the following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; delays or obstacles in launching our clinical trials; changes in legislation; inability to timely develop and introduce new technologies, products and applications; lack of validation of our technology as we progress further and lack of acceptance of our methods by the scientific community; inability to retain or attract key employees whose knowledge is essential to the development of our products; unforeseen scientific difficulties that may develop with our process; greater cost of final product than anticipated; loss of market share and pressure on pricing resulting from the competition; and laboratory results that do not translate to equally good results in real settings, all of which could cause the actual results or performance to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, Todos Medical does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risks and uncertainties affecting Todos Medical, please refer to its reports filed from time to time with the U.S. Securities and Exchange Commission.
Todos Corporate Contact:
Daniel Hirsch CFO
Todos Medical
917-983-4229 x 104
[email protected]
Todos Press Contact:
Giancarlo Greager
TreviPR
702-768-1906
[email protected]
Artificial Intelligence
Internet of Things (IoT) in Smart Cities Market: Driving Adoption for a USD 795.98 Billion Future by 2031| SkyQuest Technology
WESTFORD, Mass., July 5, 2024 /PRNewswire/ — According to SkyQuest, the global Internet of Things (IoT) in Smart Cities Market size was valued at USD 148.60 billion in 2022 poised to grow from USD 179.06 billion in 2023 to USD 795.98 billion by 2031, growing at a CAGR of 20.5% in the forecast period (2024-2031).
The innovative IoT based smart city solutions are increasing the demand in various sectors. These solutions include analytics, security, cloud, and network connectivity. One of the major drivers of market expansion in smart cities is the rise of government initiatives and smart city projects. Growth in the use of IoT technologies for control and monitoring is expected to drive the market. High urban population density contributes to the growth. IoT devices, sensors and data analytics are all integrated into the concept of “smart cities” to enhance urban growth, efficiency and sustainability.
Download a detailed overview:
https://www.skyquestt.com/sample-request/internet-of-things-in-smart-cities-market
Internet of Things (IoT) in Smart Cities Market Overview:
Report Coverage
Details
Market Revenue in 2023
USD 179.06 billion
Estimated Value by 2031
USD 795.98 billion
Growth Rate
Poised to grow at a CAGR of 20.5%
Forecast Period
2024–2031
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Offering and Application
Geographies Covered
North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Evolving IoT Technology and Urban Transformation
Key Market Drivers
Rise in Adoption of IoT Technology
Segments covered in Internet of Things (IoT) in Smart Cities Market are as follows:
OfferingSolutions (Remote Monitoring, Real Time Location System, Data Management, Reporting and Analytics, Security, Network Management), And Services (Professional Services {Consulting, System Integration and Deployment, Support and Maintenance}, And Managed Services)ApplicationSmart Transportation, Smart Building, Utilities, Citizen Services (Education, Healthcare, Public Safety)Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/internet-of-things-in-smart-cities-market
Smart Infrastructure: IoT Offerings Shaping Tomorrow’s Cities
The solutions segment accounted for the largest share and dominate the market. The global internet of things (IoT) in smart cities market offers practical innovative solutions focused on integrated information that stores, processes and acts on large amounts of data generated by networked devices for real-time location system optimization and remote monitoring facilitates better monitoring and faster response.
On the other hand, the services segment of the global market is expected to grow the fastest in the smart city market. First, the challenges of adopting IoT solutions are increasing the need for consulting, integration and managed services, which require specialized skills. Second, cities depend on them tasks are raised to build, deploy and control customized solutions while aiming to maximize the value of IoT systems.
View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/internet-of-things-in-smart-cities-market
Transforming Urban Living: IoT Applications in Smart Cities
Real-time traffic management, predictive maintenance, and advanced public transport planning enabled by communication technologies and data analytics are the main areas of current innovation and applications in smart transportation in the world. There is scarcity of resources, pollution and traffic, and increased accessibility and security. Transportation is the largest segment in the global market by application.
In the market, public sector service centers are expected to grow rapidly due to the global IoT’s ability to improve lives for its inhabitants. It provides smart classrooms by academically enhancing the learning experience. IoT in healthcare enables smarter, more efficient and more efficient patient management, thus contributing to market expansion. It also provides comprehensive surveillance systems and emergency response measures that affect public safety. They have the potential to improve urban growth, efficiency and quality of life. Growing growth in IoT technology and public safety concerns are driving the rapid growth of the segment.
Smart Cities, Smarter Future: The Role of IoT
The Internet of Things (IoT) is changing the way smart cities work, offering unprecedented connectivity and integration. As cities become more connected, the use of IoT technology seamless integration becomes increasingly important in a sustainable environment. These connected devices and sensors can collect and analyze data in real time, allowing for more informed decision making.
Related Reports:
Internet Of Things (IoT) Market
IoT Security Market
Narrowband-IoT (NB-IoT) Market
Consumer IoT Market
Internet of Things (IoT) Professional Services Market
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization has expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact:Mr. Jagraj SinghSkyquest Technology1 Apache Way,Westford,Massachusetts 01886USA (+1) 351-333-4748Email: [email protected] Our Website: https://www.skyquestt.com/
Logo: https://mma.prnewswire.com/media/2446095/SkyQuest_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/internet-of-things-iot-in-smart-cities-market-driving-adoption-for-a-usd-795-98-billion-future-by-2031-skyquest-technology-302189928.html
Artificial Intelligence
Cloud Security Market Will Surpass USD 147.45 Billion by 2031; Rise of Cloud Computing to Aid Growth| SkyQuest Technology
WESTFORD, Mass., July 5, 2024 /PRNewswire/ — According to SkyQuest, the global Cloud Security Market size was valued at USD 33.5 billion in 2022 and is poised to grow from USD 39.5 billion in 2023 to USD 147.45 billion by 2031, growing at a CAGR of 17.9% in the forecast period (2024-2031).
Increase in complexity of cyberattacks and data breaches has bolstered the demand for novel cloud security solutions around the world. The rising use of cloud technologies and platforms on a global level is also boosting the cloud security market growth. The high use of cloud computing and edge computing services by multiple organizations also creates a high demand for better cloud security infrastructure. The global cloud security market is segmented into type, service model, offering, end user, and region.
Download a detailed overview:https://www.skyquestt.com/sample-request/cloud-security-market
Cloud Security Market Overview:
Report Coverage
Details
Market Revenue in 2023
USD 39.5 billion
Estimated Value by 2031
USD 147.45 billion
Growth Rate
Poised to grow at a CAGR of 17.9%
Forecast Period
2024–2031
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Type, Service Model, End-User and Offering
Geographies Covered
North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Digital Transformation Fortifying Cloud Security with AI and ML
Key Market Drivers
Rising demand for Cloud Computing and Cybersecurity through Advanced Data Solutions
Segments covered in Cloud Security Market are as follows:
TypeLegal Issues, Compliance, Governance, Virtualization, Data Security, Interface, Network SecurityService ModelSaaS (Software as a Service), IaaS (Infrastructure as a Service), PaaS (Platform as a Service)End-UserAerospace & Defence, Government, BFSI, Healthcare, IT, Telecommunication, Manufacturing, Retail, Energy & Utilities, Media & Entertainment, OthersOfferingSolutions, ServicesRequest Free Customization of this report:https://www.skyquestt.com/speak-with-analyst/cloud-security-market
Compliance to Remain a Key Cloud Security Concern for All Companies through 2031
Compliance has always been a key part of any security solution and the same is also true for cloud security as well. Regulatory bodies and governments have been implementing stricter laws and mandates to ensure the safety of data on cloud platforms. Ensuring compliance with these norms is essential for any cloud service provider, which is why a security solution that understands and manages compliance is always in demand. Ensuring cross-border compliance could help cloud security companies get more bang for their buck in the future.
Legal issues and data privacy concerns are also estimated to drive up the demand for novel cloud security solutions. Complex legal and regulatory frameworks are also contributing to the high adoption of cloud security with legal security features as well. Data and network security are also important aspects that cloud security providers need to emphasize going forward.
Cloud security Solutions to Remain Essential Securing a Cloud Environment
Cloud security solutions powered by artificial intelligence and other advanced technologies are being developed around the world. Deployment of different solutions for enterprise and individual cloud applications will also create new opportunities for cloud security market players over the coming years. Data loss prevention and disaster recovery are some key features of cloud security solutions that most companies are trying to improve. Meanwhile, the rapid adoption of cloud security is also creating a high demand for cloud security services as well. Cloud security providers are continually focusing on improving their services by offering round-the-clock support and predictive threat management services.
View report summary and Table of Contents (TOC):https://www.skyquestt.com/report/cloud-security-market
High Use of Cloud Platforms and Technologies in the IT Industry Creates an Opportune Setting for Cloud Security Vendors
The information technology (IT) industry has always led the adoption of novel technologies and the cloud is one of them. The rising use of cloud platforms and migration of traditional technologies in cloud environments are boosting the demand for cloud security in the IT industry. The BFSI industry will also offer new moneymaking scope for cloud security providers as it moves towards digitization and the incidence of digital frauds increases. Telecommunication end users are also expected to bolster the demand for novel cloud security solutions as they utilize cloud technology to become digital service providers. Adoption of automation and smart manufacturing practices in the manufacturing space will also promote the use of cloud platform, which in turn, is expected to boost cloud security demand as well.
Cloud security companies have a lot of potential to expand their business in many industry verticals. New companies can focus on providing services to build a strong market presence and then move on to making cloud security solutions to compete with the leading market players.
Related Report:
Cyber Security Market
Network Security Market
Endpoint Security Market
Managed Security Services Market
Application Security Market
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization has expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact:Mr. Jagraj SinghSkyquest Technology1 Apache Way,Westford,Massachusetts 01886USA (+1) 351-333-4748Email: [email protected] Our Website: https://www.skyquestt.com/
Logo: https://mma.prnewswire.com/media/2446095/SkyQuest_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/cloud-security-market-will-surpass-usd-147-45-billion-by-2031-rise-of-cloud-computing-to-aid-growth-skyquest-technology-302189958.html
Artificial Intelligence
Application Security Market to Surpass USD 17.51 Billion by 2031; Rising Incidence of Cyberattacks to Drive Market | SkyQuest Technology
WESTFORD, Mass., July 5, 2024 /PRNewswire/ — According to SkyQuest, the global Application Security Market size was valued at USD 5.28 Billion in 2022 and is poised to grow from USD 6.08 Billion in 2023 to USD 17.51 Billion by 2031, growing at a CAGR of 14.14 % during the forecast period (2024-2031).
High reliance on applications and growing digitization around the world are key factors that promote the demand for application security. Increasing sophistication and frequency of cyberattacks on a global scale is also predicted to augment the application security market growth trajectory across the forecast period. The imposition of stringent safety mandates by regulatory bodies is also bolstering the demand for better application security solutions. The global application security market is segmented into component, deployment mode, organization size, vertical, and region.
Download a detailed overview:
https://www.skyquestt.com/sample-request/application-security-market
Application Security Market Overview:
Report Coverage
Details
Market Revenue in 2023
USD 6.08 billion
Estimated Value by 2031
USD 17.51 billion
Growth Rate
Poised to grow at a CAGR of 14.14%
Forecast Period
2024–2031
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Type, Component, Deployment Model, Organization Size and Verticals
Geographies Covered
North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Increased Number of Sophisticated Attacks
Key Market Drivers
The Rising Demands for Regulatory Compliance within Solution
Segments covered in Application Security Market are as follows:
TypeWeb Application Security, and Mobile Application SecurityComponentSolutions (Security Testing Tools (Static Application Security Testing (SAST), Dynamic Application Security Testing (DAST), Interactive Application Security Testing (IAST), Runtime Application Self-Protection (RASP)) Container Security, API Security, and Others Solution), and Services (Professional Services, (Consulting services, Training & Education, Integration and maintenance, Penetration Testing) Managed Services)Deployment ModeCloud and on-premisesOrganization SizeLarge Enterprises, and Small & Medium EnterprisesVerticalsBFSI, Healthcare, IT & ITES, Telecommunication, Manufacturing, Government and Public Sector, Retail & E-commerce, Education, and OthersRequest Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/application-security-market
On-premises Deployment of Application Security Solutions is Preferred for its Better Control and Flexibility
On-premises application security solutions and systems are usually handled by a company’s own employees, and this is why they are somewhat safer from cyberattacks or breaches. Little to no involvement of external personnel in the management and operation of on-premises application security is what gives the users and organizations the satisfaction of a better-secured application. Large enterprises are more inclined to opt for such solutions as this requires substantial capital investment and commitment over the long term.
Most application security companies are projected to target cloud deployment owing to rising awareness and acceptance of cloud technologies and platforms. Advancements in cloud computing technologies and the high emphasis of organizations on improving resource utilization are predicted to favor the demand for cloud-based application security solutions in the future.
View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/application-security-market
Large Enterprises More Inclined to opt for Application Security Solutions Owing to Their High Spending Capacity
Large enterprises use a variety of applications to ensure their operations and infrastructure run as intended. This includes third-party apps as well as internal company applications. The security of these applications is the priority as any lapses in them could lead to devastating data breaches and cyberattacks. Rising spending on large enterprises on improving their cybersecurity and specialized emphasis on application security is also making this segment an important one for application security providers. Small and medium enterprises (SMEs) are also expected to create new opportunities for application security companies in the future as application security becomes more affordable and important.
Software Tools to Remain Quintessential in Creating and Managing Application Security
Application security testing software is a key segment where almost all application security companies are focusing. Ensuring proper testing of application security is an essential task and any lapses in this could lead to vulnerabilities in applications that hackers can exploit. Multiple testing tools and testing approaches are being explored to ensure the efficacy of application security solutions.
Dynamic Application Security Testing (DAST) is gaining massive popularity around the world and all application security companies are trying to take this approach to maximize the security of their offerings. Investing in application security testing tools will never be a bad choice for any company looking to make a mark in the global application security market going forward.
Application security providers need to stay updated with new threats and incorporate the same in their products to stay relevant in the market. Investments in development of new application security solutions with advanced technologies and features should be the focus of upcoming as well as established application security market players in the long run.
Related Report:
Cyber Security Market
Blockchain Identity Management Market
Secure Access Service Edge Market
Zero Trust Security Market
Endpoint Security Market
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization has expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact:
Mr. Jagraj Singh SkyQuest Technology1 Apache Way,Westford,Massachusetts 01886USA (+1) 351-333-4748Email: [email protected] Our Website: https://www.skyquestt.com/
Logo: https://mma.prnewswire.com/media/2446095/SkyQuest_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/application-security-market-to-surpass-usd-17-51-billion-by-2031-rising-incidence-of-cyberattacks-to-drive-market–skyquest-technology-302189924.html
-
Artificial Intelligence4 days agoConsole Connect Recognized with Frost & Sullivan’s 2024 Global Technology Innovation Leadership Award for Its Outstanding Automation and Blockchain Solutions
-
Uncategorized3 days agoGSA Announces AI-Themed Hackathon
-
Uncategorized3 days ago
ATO Stepping Up AI Capabilities to Be Leader by 2030
-
Artificial Intelligence3 days agoViking Analytics & Bharat Forge signs a 3 year contract
-
Uncategorized3 days ago
Auditchain Labs AG Announces Roll-Out of Pacioli AI for Compliance with MiCA and VARA White Paper Disclosures
-
Uncategorized3 days agoHow Financial Institutions Can Get Their AI Strategy Right
-
Artificial Intelligence4 days agoCreator-first AI x Blockchain Project Animechain.ai Reveals Its White Paper and Participation in IVS Crypto 2024 KYOTO as a Platinum Sponsor
-
Uncategorized3 days ago
AImotive Achieves ISO 26262 ASIL-D Re-Certification for aiSim 5
